| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Loratadine | FAERS: 4 | US FAERS | |
| 2 | Naproxen | FAERS: 4 | US FAERS | |
| 3 | Loperamide | FAERS: 3 | US FAERS | |
| 4 | Acetaminophen | FAERS: 2 | US FAERS | |
| 5 | Imodium Multi-Symptom Relief | FAERS: 2 | US FAERS | |
| 6 | fexofenadine | FAERS: 2 | US FAERS | |
| 7 | 1-N'-[2-[[5-[(Dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;hydron;chloride | FAERS: 1 | US FAERS | |
| 8 | Azithromycin | FAERS: 1 | US FAERS | |
| 9 | Ciprodex | FAERS: 1 | US FAERS | |
| 10 | Everolimus | FAERS: 1 | US FAERS | |
| 11 | Guaifenesin | FAERS: 1 | US FAERS | |
| 12 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 13 | Lidoderm | FAERS: 1 | US FAERS | |
| 14 | Methotrexate | FAERS: 1 | US FAERS | |
| 15 | Oxycodone | FAERS: 1 | US FAERS | |
| 16 | Tadenan | FAERS: 1 | US FAERS | |
| 17 | Testosterone | FAERS: 1 | US FAERS | |
| 18 | Vancomycin | FAERS: 1 | US FAERS | |
| 19 | difluprednate | FAERS: 1 | US FAERS | |
| 20 | lenvatinib | FAERS: 1 | US FAERS | |
| 21 | teriflunomide | FAERS: 1 | US FAERS | |
| 22 | dorzolamide | Canada Vigilance: 1 | Canada Vigilance | |
| 23 | lifitegrast | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.